Hyperglycemia clinical trials

Explore recruiting hyperglycemia clinical trials.

Recruiting hyperglycemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperglycemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of time of alpelisib administration, concomitant fasting and low carbohydrate diet on alpelisib toxicity and efficacy; a pilot randomized controlled phase IIb trial- ITACA

Croatia

Therapeutic exploratory (Phase II) EU CTIS Study details

GALOP: Oral Glibenclamide in premature hyperglycemia

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Impact of Tight blood Glucose Control within normal fasting ranges with insulin titration prescribed by the Leuven algorithm in adult critically ill patients.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor

Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Experimental hypothermia using cold ambient temperature and drug-induced inhibition of shivering in awake, healthy volunteers: a crossover, double blinded trial

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

SEQUence of Endocrine therapy in advanced Luminal Breast cancer (SEQUEL-Breast): A phase 2 study on fulvestrant beyond progression in combination with alpelisib for PIK3CA-mutated, hormone-receptor positive HER2 negative advanced breast cancer

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Hyperglycemia trials by city

Hyperglycemia in Toronto Hyperglycemia in Vancouver Hyperglycemia in Montreal Hyperglycemia in Calgary Hyperglycemia in Edmonton Hyperglycemia in Ottawa Hyperglycemia in Winnipeg Hyperglycemia in Quebec City Hyperglycemia in Hamilton Hyperglycemia in Kitchener Hyperglycemia in London Hyperglycemia in Halifax Hyperglycemia in New York Hyperglycemia in Los Angeles Hyperglycemia in Chicago Hyperglycemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease